Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $79
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Nigel Dally has maintained an Overweight rating on MetLife (NYSE:MET) and raised the price target from $78 to $79.
August 18, 2023 | 1:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Overweight rating on MetLife and raised the price target from $78 to $79.
The news is directly related to MetLife. The Overweight rating maintained by Morgan Stanley indicates a positive outlook for the company. The increase in price target from $78 to $79 suggests that the analyst sees potential for the stock's price to rise in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100